ALN-4324

· Alnylam Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ALN-4324, covering 2026-04-17 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate ALN-4324 on Insulin Sensitivity in Adults With Type 2 Diabetes Mellitus [Phase 2]